KBC Group NV lessened its stake in Genpact Limited (NYSE:G – Free Report) by 38.9% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 4,439 shares of the business services provider’s stock after selling 2,827 shares during the period. KBC Group NV’s holdings in Genpact were worth $195,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. JPMorgan Chase & Co. increased its stake in shares of Genpact by 20.9% during the first quarter. JPMorgan Chase & Co. now owns 4,111,340 shares of the business services provider’s stock worth $207,129,000 after acquiring an additional 710,704 shares during the period. Alliancebernstein L.P. boosted its holdings in Genpact by 4.1% in the 1st quarter. Alliancebernstein L.P. now owns 3,045,542 shares of the business services provider’s stock valued at $153,434,000 after purchasing an additional 118,689 shares in the last quarter. Nordea Investment Management AB increased its position in Genpact by 60.2% during the 2nd quarter. Nordea Investment Management AB now owns 2,617,255 shares of the business services provider’s stock worth $114,924,000 after purchasing an additional 983,774 shares during the period. Sumitomo Mitsui Trust Group Inc. raised its stake in shares of Genpact by 8.8% during the 2nd quarter. Sumitomo Mitsui Trust Group Inc. now owns 2,501,688 shares of the business services provider’s stock worth $110,099,000 after buying an additional 203,015 shares in the last quarter. Finally, Ameriprise Financial Inc. lifted its holdings in shares of Genpact by 109.8% in the 1st quarter. Ameriprise Financial Inc. now owns 1,615,220 shares of the business services provider’s stock valued at $81,375,000 after buying an additional 845,393 shares during the period. 96.03% of the stock is owned by hedge funds and other institutional investors.
Insider Buying and Selling
In related news, CEO Balkrishan Kalra sold 55,000 shares of the stock in a transaction on Thursday, September 11th. The stock was sold at an average price of $43.36, for a total transaction of $2,384,800.00. Following the sale, the chief executive officer owned 295,246 shares of the company’s stock, valued at $12,801,866.56. This trade represents a 15.70% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Sameer Dewan sold 26,531 shares of the business’s stock in a transaction dated Tuesday, November 11th. The shares were sold at an average price of $44.70, for a total transaction of $1,185,935.70. Following the completion of the transaction, the senior vice president directly owned 62,617 shares of the company’s stock, valued at $2,798,979.90. The trade was a 29.76% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 161,183 shares of company stock worth $6,970,760 in the last ninety days. 2.80% of the stock is currently owned by insiders.
Genpact Stock Performance
Genpact (NYSE:G – Get Free Report) last issued its quarterly earnings data on Thursday, November 6th. The business services provider reported $0.97 earnings per share for the quarter, topping analysts’ consensus estimates of $0.90 by $0.07. Genpact had a net margin of 11.01% and a return on equity of 22.55%. The business had revenue of $1.29 billion during the quarter, compared to analysts’ expectations of $1.27 billion. During the same period last year, the company posted $0.85 EPS. The company’s revenue was up 6.6% on a year-over-year basis. Genpact has set its FY 2025 guidance at 3.600-3.610 EPS. Q4 2025 guidance at 0.930-0.940 EPS. As a group, research analysts predict that Genpact Limited will post 3.21 EPS for the current fiscal year.
Genpact Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 23rd. Stockholders of record on Tuesday, December 9th will be given a $0.17 dividend. This represents a $0.68 annualized dividend and a dividend yield of 1.6%. The ex-dividend date is Tuesday, December 9th. Genpact’s dividend payout ratio is currently 21.94%.
Wall Street Analyst Weigh In
Several research analysts have issued reports on G shares. JPMorgan Chase & Co. cut their price objective on Genpact from $55.00 to $50.00 and set a “neutral” rating for the company in a research report on Wednesday, August 20th. Wall Street Zen upgraded shares of Genpact from a “hold” rating to a “buy” rating in a research note on Saturday. Needham & Company LLC upped their target price on shares of Genpact from $50.00 to $53.00 and gave the stock a “buy” rating in a research report on Friday, August 8th. Weiss Ratings reiterated a “hold (c)” rating on shares of Genpact in a research report on Wednesday, October 8th. Finally, Citigroup raised Genpact to a “hold” rating in a research note on Thursday, October 23rd. Three investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $51.13.
Check Out Our Latest Research Report on Genpact
About Genpact
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Read More
- Five stocks we like better than Genpact
- What is a Stock Market Index and How Do You Use Them?
- What’s on the Thanksgiving Table? A Stock Pick for Every Course
- Golden Cross Stocks: Pattern, Examples and Charts
- Why Home Depot’s Pain Could Be a Long-Term Investor’s Gain
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Qualcomm’s Bulls Are Running Out of Room to Be Wrong
Want to see what other hedge funds are holding G? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Genpact Limited (NYSE:G – Free Report).
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.
